Evidence map›Paper›PMID 38824199›Full record

ArticleChild psychiatry and human development2026

Patterns of Psychotropic Prescribing Practices in Autistic Children and Adolescents: An Australian Perspective of Two Cohorts Five Years Apart.

Anna Baldes, Tamara May, Amanda Brignell, Katrina Williams

Abstract read
In one paragraph

Article in Child psychiatry and human development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna BaldesDepartment of Paediatrics, Monash University, Clayton, VIC, Australia. anna.baldes@monash.edu.
Tamara MayDepartment of Paediatrics, Monash University, Clayton, VIC, Australia.
Amanda BrignellDepartment of Paediatrics, Monash University, Clayton, VIC, Australia.
Katrina WilliamsDepartment of Paediatrics, Monash University, Clayton, VIC, Australia.ORCID http://orcid.org/0000-0002-1686-4458

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to describe the utilisation of psychotropic medications in Australian autistic children and adolescents. All children and adolescents with available Pharmaceutical Benefits Scheme data who endorsed an autism diagnosis in The Longitudinal Study of Australian Children, including both B (n = 233, age 0-1 years in wave 1) and K cohorts (n = 157, age 4-5 years in wave 1), were included to describe psychotropic prescribing patterns. 212 (54.4%) autistic children and adolescents received at least one psychotropic prescription and 99 (25.4%) had polypharmacy. The most common psychotropic class prescribed was antidepressants (31.3%). Children in the B cohort were more likely to have a parent-reported diagnosis of anxiety or depression (χ

Indexed as

Autistic DisorderPractice Patterns, Physicians'Psychotropic DrugsAdolescentAustraliaChildChild, PreschoolFemaleHumansInfantInfant, NewbornLongitudinal StudiesMalePolypharmacyPsychotropic DrugsAustraliaAutismAutism spectrum disorderDrug utilisationPsychotropic drugs

Identifiers

PMID38824199
PMCPMC13128738

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.